# Arcus Biosciences Inc. (RCUS) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | -$386M |
| 2024 | -$330M |
| 2023 | -$340M |
| 2022 | -$280M |
| 2021 | $54M |
| 2020 | -$124M |
| 2019 | -$89M |
| 2018 | -$55M |
| 2017 | -$53M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | -$134M |
| 2025-09-30 | -$142M |
| 2025-06-30 | -$8M |
| 2025-03-31 | -$122M |
| 2024-09-30 | -$105M |
| 2024-06-30 | -$106M |
| 2024-03-31 | -$16M |
| 2023-09-30 | -$80M |
| 2023-06-30 | -$83M |
| 2023-03-31 | -$86M |
| 2022-09-30 | -$70M |
| 2022-06-30 | -$69M |
| 2022-03-31 | -$67M |
| 2021-09-30 | -$78M |
| 2021-06-30 | -$76M |
| 2021-03-31 | -$73M |
| 2020-09-30 | $2M |
| 2020-06-30 | -$45M |
| 2020-03-31 | -$28M |
| 2019-09-30 | -$23M |
| 2019-06-30 | -$29M |
| 2019-03-31 | -$19M |
| 2018-09-30 | -$12M |
| 2018-06-30 | -$16M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/RCUS/operating-income)